180 related articles for article (PubMed ID: 9066940)
1. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
Tonn ME; Schaiff RA; Kollef MH
Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
[TBL] [Abstract][Full Text] [Related]
2. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome.
Slocum MM; Adams JG; Teel R; Spadone DP; Silver D
J Vasc Surg; 1996 May; 23(5):839-43. PubMed ID: 8667505
[TBL] [Abstract][Full Text] [Related]
3. [Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].
Illes M; Klaus S; Simon JC; Treudler R
Hautarzt; 2011 Apr; 62(4):290-2. PubMed ID: 20835809
[TBL] [Abstract][Full Text] [Related]
4. A Rare Case of Enoxaparin-Induced Skin Necrosis Without Thrombocytopenia.
Li J; Inwald G; Thomas M
Am J Phys Med Rehabil; 2019 May; 98(5):e51. PubMed ID: 30252691
[No Abstract] [Full Text] [Related]
5. Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis.
Drakos P; Uziely B; Nagler A; Gillis S; Eldor A
Haemostasis; 1993; 23(5):259-62. PubMed ID: 8175046
[TBL] [Abstract][Full Text] [Related]
6. Rare presentation of enoxaparin-induced skin necrosis in a postoperative patient.
Byrne EM; Khattab A; Chen F; Bhagavatula R
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35418382
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of enoxaparin induced thrombocytopenia in intensive care unit.
Giuliani E; Melegari G; Farinetti A; Barbieri A; Mattioli AV
Ann Ital Chir; 2015; 86():545-7. PubMed ID: 26612035
[TBL] [Abstract][Full Text] [Related]
8. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
Warkentin TE; Levine MN; Hirsh J; Horsewood P; Roberts RS; Gent M; Kelton JG
N Engl J Med; 1995 May; 332(20):1330-5. PubMed ID: 7715641
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin-induced thrombocytopenia in a child.
Dager WE; White RH
Ann Pharmacother; 2004 Feb; 38(2):247-50. PubMed ID: 14742760
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous dalteparin reactions associated with antibodies of heparin-induced thrombocytopenia.
Payne SM; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):655-8. PubMed ID: 12708940
[TBL] [Abstract][Full Text] [Related]
12. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
13. Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Yazbek MA; Velho P; Nadruz W; Mahayri N; Appenzeller S; Costallat LT
J Clin Rheumatol; 2012 Jun; 18(4):196-8. PubMed ID: 22647862
[TBL] [Abstract][Full Text] [Related]
14. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
[TBL] [Abstract][Full Text] [Related]
16. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
18. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
Bream-Rouwenhorst HR; Hobbs RA
Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
Br J Surg; 1997 Aug; 84(8):1099-103. PubMed ID: 9278651
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity to subcutaneous enoxaparin.
Méndez J; Sanchís ME; de la Fuente R; Stolle R; Vega JM; Martínez C; Armentia A; Sánchez P; Fernández A
Allergy; 1998 Oct; 53(10):999-1003. PubMed ID: 9821483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
